The research behind Autonomic Health
Autonomic Health was built on more than two decades of clinical insight. Our co-founder, Dr. Ramesh Adiraju, spent over 20 years identifying dysautonomia — dysregulation of the autonomic nervous system — as the hidden root cause driving dozens of modern chronic conditions.


Dr. Ramesh Adiraju, MD, FACC is an interventional cardiologist and the clinical architect of Autonomic Health's dysautonomia research program. After completing fellowship training in Interventional Cardiology at Lankenau Hospital, Philadelphia (1993), he joined private practice in Lower Bucks County, Pennsylvania — where he would spend the next three decades treating cardiovascular patients while quietly building a parallel body of research into the autonomic nervous system.
Over 20 years of clinical investigation led him to a unifying insight: that dysautonomia — an imbalance in the autonomic nervous system's two branches — underlies the onset and perpetuation of a remarkably wide range of chronic conditions, from Chronic Heart Failure and Type 2 Diabetes to POTS, Fibromyalgia, PTSD, and Long COVID syndrome.
That insight is the foundation of Autonomic Health.
PATIENTS FROM TOP U.S. MEDICAL CENTERS





"A poorly functioning central autonomic system — a dysautonomia state — may be the root cause of many modern diseases including CHF, Type II diabetes, hypertension, ADHD, PTSD, migraine, and chronic fatigue."
Modern medicine is organized around organs and specialties. Patients, however, often experience symptoms that span multiple systems simultaneously.
Dr. Ramesh Adiraju's work approached this differently — by focusing on the autonomic nervous system, the body's continuous control system for cardiovascular function, metabolism, sleep, and recovery. It operates through two branches: the sympathetic ('fight or flight') and the parasympathetic ('rest and digest').
In optimal health, these branches maintain autonomic coherence. When this breaks down — when one chronically over- or under-fires — the result is dysautonomia.
Over two decades, this work led to clinical protocols for assessing and treating dysautonomia across multiple conditions. Autonomic Health extends this foundation into a wearable-native, AI-driven platform.
The CCAL is the brainstem's auto-regulatory control system — a continuous feedback loop coordinating all involuntary organ functions through balanced Sympathetic (SNS) and Parasympathetic (PSNS) signaling.
When the loop functions normally, the body maintains Pitch Tone, hormonal balance, and vascular homeostasis.
When dysautonomia disrupts it, the cascade predisposes to Type 2 Diabetes, vascular inflammation, and multi-system chronic disease.
Central Vagal Nucleus — midline brainstem hub. Acetylcholine-secreting; coordinates the entire CCAL loop.
Key control center of the limbic system. Regulates emotional responses, stress reactions, and autonomic output.
Reactive (fight-or-flight) branch. Overactivation causes chronic stress, vascular inflammation, and T2DM.
Midline regulatory branch via CVN. Controls organ recovery, hormonal replenishment, and sleep cycles.
Peripheral A-V capillary tone maintained by balanced SNS & PSNS. Foundation of vascular and cerebral homeostasis.
POTS, syncope, orthostatic hypotension, and related hemodynamic instability driven by autonomic failure.
ME/CFS, Long COVID, and post-viral syndromes where dysautonomia is the primary recovery bottleneck.
Type II diabetes, systemic vasculopathy, and metabolic syndrome mediated by autonomic imbalance.
Fibromyalgia, erythromelalgia, IBS, and reflex sympathetic dystrophy — complex conditions with shared autonomic etiology.
ADHD, PTSD, central sleep apnea, and restless leg syndrome treated through the HPV axis and ANS modulation.
Advanced cardiac dysfunction treated with combined dysautonomia regulation and hemodynamic support protocols.
In 200+ patients with severe left ventricular dysfunction, combined protocol achieved LV recovery to >45% EF in all patients. Zero required ICD device therapy.
Identified specific autonomic abnormalities in Long COVID patients consistent with ME/CFS presentations, leveraging integrative modulation protocols to extraordinary success. 250+ patients fully recovered from Long COVID.
500+ patients with Type II diabetes weaned off insulin; ADD/ADHD taken off stimulants; hypertension taken off polypharmacy; sleep apnea eliminated from CPAP dependence.



20+ years of dysautonomia research, clinical testing, and protocol development at Dysautonomia Research Institute.
The autonomic nervous system identified as the upstream control system — a unified explanation for diverse chronic conditions.
Wearables + AI + longitudinal care built on the same clinical protocols that reversed heart failure and treated 15+ conditions.
Institutional Research Archive

Twenty years of clinical research. Now available as a real-time autonomic health platform.